This could put pressure on European Securities and Markets Authority (ESMA) which has derecognised CCIL. The standoff between RBI and European financial regulators stems from the latter’s demands which the Indian central bank believes is extra-territorial.
Aarti Pharmalabs shares rally over 33% in two days post Q1 results. What is driving the surge?
Aarti Pharmalabs shares have surged 33% in two days after the company reported a 65.4% year-on-year rise in Q1FY27 profit and 38.7% growth in revenue.